(Q45263252)

11 December 2017

title

Attenuation of retinal vascular development and neovascularization during oxygen-induced ischemic retinopathy in Bcl-2-/- mice (English)

1 reference

11 December 2017

1 reference

Shoujian Wang

1 reference

11 December 2017

Christine M Sorenson

series ordinal

1 reference

11 December 2017

Nader Sheibani

series ordinal

1 reference

11 December 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

11 December 2017

1 reference

inferred from page(s)

published in

Developmental Biology

1 reference

11 December 2017

volume

279

1 reference

11 December 2017

1 reference

11 December 2017

page(s)

205-219

1 reference

Bcl-2 overexpression and hypoxia synergistically act to modulate vascular endothelial growth factor expression and in vivo angiogenesis in a breast carcinoma line.

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.12.017

Hyperoxia-induced apoptosis does not require mitochondrial reactive oxygen species and is regulated by Bcl-2 proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.12.017

Retinal ganglion cell loss after the period of naturally occurring cell death in bcl-2-/- mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.12.017

Endostatin induces endothelial cell apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.12.017

Bcl-2 is not required in retinal ganglion cells surviving optic nerve axotomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.12.017

Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.12.017

Vascular smooth muscle maintains the levels of Bcl-2 in endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.12.017

Regression of the hyaloid vessels and pupillary membrane of the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.12.017

Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.12.017

Apoptosis and adaptive responses to oxidative stress in human endothelial cells exposed to cyclosporin A correlate with BCL-2 expression levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.12.017

Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.12.017

Hypoxia-induced endothelial apoptosis through nuclear factor-kappaB (NF-kappaB)-mediated bcl-2 suppression: in vivo evidence of the importance of NF-kappaB in endothelial cell regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.12.017

Bcl-2 accelerates the maturation of early sensory neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.12.017

Expression of Bcl-2 protects against photoreceptor degeneration in retinal degeneration slow (rds) mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.12.017

Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.12.017

Apoptosis causes lumen formation during angiogenesis in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.12.017

Endothelial cell apoptosis in capillary network remodeling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.12.017

In vivo formation of complex microvessels lined by human endothelial cells in an immunodeficient mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.12.017

Engraftment of a vascularized human skin equivalent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.12.017

Inhibition of programmed cell death impairs in vitro vascular-like structure formation and reduces in vivo angiogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.12.017

Bcl-2 expression during the development and degeneration of RCS rat retinae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.12.017

Bcl-2 family members and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.12.017

Retinal organization in the bcl-2-overexpressing transgenic mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.12.017

Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.12.017

Vascular cell apoptosis in remodeling, restenosis, and plaque rupture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.12.017

Thrombospondin-1-deficient mice exhibit increased vascular density during retinal vascular development and are less sensitive to hyperoxia-mediated vessel obliteration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.12.017

Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.12.017

10.1016/J.YDBIO.2004.12.017

7 January 2021

Identifiers

DOI

1 reference

11 December 2017

1 reference